INHIBITION OF MONOAMINE-OXIDASE BY 2 SUBSTRATE-ANALOGS, WITH DIFFERENT PREFERENCES FOR 5-HYDROXYTRYPTAMINE NEURONS

被引:7
作者
KIM, SK
TOYOSHIMA, Y
ARAI, Y
KINEMUCHI, H
TADANO, T
OYAMA, K
SATOH, N
KISARA, K
机构
[1] ISHINOMAKI SENSHU UNIV,FAC SCI & ENGN,BIOL CHEM LAB,MINAMISAKAI,ISHINOMAKI 986,JAPAN
[2] SHOWA UNIV,SCH MED,DEPT PHARMACOL,SHINAGAWA KU,TOKYO 142,JAPAN
[3] TOHOKU COLL PHARMACEUT SCI,DEPT PHARMACOL,AOBA KU,SENDAI 981,JAPAN
关键词
5-FLUORO-ALPHA-METHYLTRYPTAMINE; PARA-CHLORO-BETA-METHYLPHENETHYLAMINE; MONOAMINE OXIDASE (MAO); HEAD-TWITCH RESPONSE; 5-HYDROXYTRYPTAMINE (5-HT) NEURON; PHENELZINE;
D O I
10.1016/0028-3908(91)90057-I
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Various intraperitoneal doses of 5-fluoro-alpha-methyltryptamine (5-FMT), given to mice, dose-dependently inhibited only MAO(A) activity, with similar degrees of inhibition in the striatum, hypothalamus and the rest of the forebrain. The activity inhibited in these regions, completely recovered to control levels within 24 hr after the injection. In contrast, p-chloro-beta-methylphenethylamine (p-CMP), selectively inhibited MAO(B) activity, with complete recovery within 45 min after the injection. Regardless of the differences in time interval and degree of inhibition of MAO(A) by 5-FMT or MAO(B) by p-CMP, both kinds of inhibition were competitive, with respect to oxidation of the respective substrate. 5-Fluoro-alpha-methyltryptamine markedly protected only MAO(A) against inhibition by phenelzine, without protecting MAO(B). Also, 5-FMT greatly increased one kind of animal behaviour, the head-twitch and this behaviour was greatly reduced by treatment with fluoxetine, but increased by reserpine. The results indicate that p-CMP is a short-acting, probably reversible, MAO(B)-selective inhibitor and 5-FMT has the same characteristics of selectivity for MAO(A) in central serotonergic neurons.
引用
收藏
页码:329 / 335
页数:7
相关论文
共 29 条
[1]   INHIBITION OF BRAIN TYPE-A MONOAMINE-OXIDASE AND 5-HYDROXYTRYPTAMINE UPTAKE BY 2 AMPHETAMINE METABOLITES, PARA-HYDROXYAMPHETAMINE AND PARA-HYDROXYNOREPHEDRINE [J].
ARAI, Y ;
KIM, SK ;
KINEMUCHI, H ;
TADANO, T ;
SATOH, SE ;
SATOH, N ;
KISARA, K .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (02) :403-408
[2]   STUDIES OF MONOAMINE-OXIDASE AND SEMICARBAZIDE-SENSITIVE AMINE OXIDASE .2. INHIBITION BY ALPHA-METHYLATED SUBSTRATE-ANALOG MONOAMINES, ALPHA-METHYLTRYPTAMINE, ALPHA-METHYLBENZYLAMINE AND 2 ENANTIOMERS OF ALPHA-METHYLBENZYLAMINE [J].
ARAI, Y ;
TOYOSHIMA, Y ;
KINEMUCHI, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 41 (02) :191-197
[4]  
BECKMANN H, 1983, MODERN PROBLEMS PHAR, V19
[5]   INDOLEAMINE ANTAGONISTS - RELATIVE POTENCIES AS INHIBITORS OF TRYPTAMINE-EVOKED EVOKED AND 5-HYDROXYTRYPTOPHAN-EVOKED RESPONSES [J].
CLINESCHMIDT, BV ;
LOTTI, VJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1974, 50 (02) :311-313
[6]   A METHOD FOR ASSESSING EFFECTS OF DRUGS ON CENTRAL ACTIONS OF 5-HYDROXYTRYPTAMINE [J].
CORNE, SJ ;
WARNER, BT ;
PICKERING, RW .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1963, 20 (01) :106-&
[7]   MONOAMINE-OXIDASE A AND B - USEFUL CONCEPT [J].
FOWLER, CJ ;
CALLINGHAM, BA ;
MANTLE, TJ ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) :97-101
[8]   SELECTIVE INHIBITORS OF MONOAMINE OXIDASE-A AND OXIDASE-B - BIOCHEMICAL, PHARMACOLOGICAL, AND CLINICAL PROPERTIES [J].
FOWLER, CJ ;
ROSS, SB .
MEDICINAL RESEARCH REVIEWS, 1984, 4 (03) :323-358
[9]   EFFECT OF AN UPTAKE INHIBITOR ON SEROTONIN METABOLISM IN RAT-BRAIN - STUDIES WITH 3-PARA-TRIFLUOROMETHYLPHENOXY)-N-METHYL-3-PHENYLPROPYLAMINE (LILLY 110140) [J].
FULLER, RW ;
PERRY, KW ;
MOLLOY, BB .
LIFE SCIENCES, 1974, 15 (06) :1161-1171